Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00711724 · ClinicalTrials.gov registry record
Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 50
- Enrollment target
NCT00711724: Completed study, sponsored by Massachusetts General Hospital.
NCT00711724 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00711724 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The primary objective is to establish the concurrent validity of the clinician administered Attention Deficit Hyperactivity Disorder-Rating Scale (ADHD-RS) and the patient administered Attention Deficit Hyperactivity Disorder Self Report Scale (ASRS) v1.1 Symptom Checklist.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00711724
The ClinicalTrials.gov registry entry for NCT00711724 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00711724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00711724 about?
NCT00711724 is a clinical study titled "Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD". The primary objective is to establish the concurrent validity of the clinician administered Attention Deficit Hyperactivity Disorder-Rating Scale (ADHD-RS) and the patient administered Attention Deficit Hyperactivity Disorder Self Report Scale (ASRS) v1.1 Symptom Checklist.
What is the current status of trial NCT00711724?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2007-07. Estimated completion is 2009-03.
Who is sponsoring clinical trial NCT00711724?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.